Cornerstone Capital Management Holdings’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
$4.59M Buy
115,100
+6,100
+6% +$243K 0.03% 493
2017
Q3
$4.36M Buy
109,000
+59,800
+122% +$2.39M 0.03% 475
2017
Q2
$2.12M Sell
49,200
-118,600
-71% -$5.11M 0.02% 710
2017
Q1
$5.25M Sell
167,800
-8,900
-5% -$279K 0.04% 448
2016
Q4
$4.46M Sell
176,700
-1,850
-1% -$46.7K 0.03% 509
2016
Q3
$4.41M Buy
178,550
+80,650
+82% +$1.99M 0.03% 503
2016
Q2
$1.99M Sell
97,900
-154,700
-61% -$3.15M 0.02% 727
2016
Q1
$3.85M Buy
252,600
+129,000
+104% +$1.97M 0.03% 540
2015
Q4
$1.66M Buy
123,600
+16,300
+15% +$219K 0.01% 784
2015
Q3
$1.51M Sell
107,300
-3,200
-3% -$44.9K 0.01% 796
2015
Q2
$1.88M Buy
+110,500
New +$1.88M 0.02% 734
2015
Q1
Sell
-23,800
Closed -$198K 1428
2014
Q4
$198K Buy
+23,800
New +$198K ﹤0.01% 1092